Therefore, comparative studies should be performed to compare the efficacy of different anti-VEGF agents and between anti-VEGF agents and intravitreal steroids, to provide insights into the optimal therapy selection in clinical practice for diverse retinal diseases. This evidence concerns the gene VEGFA and Abnormal retinal morphology.